Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
insulin
Pharma
Biocon sells insulin and other brands to Eris for $150M
Biocon and Eris have expanded a previous agreement, with Biocon selling Indian branded formulations businesses to Mumbai-based Eris for $150M.
Kevin Dunleavy
Mar 14, 2024 11:34am
Eli Lilly inks insulin pricing settlement in Minnesota
Feb 8, 2024 11:40am
FDA hits Biocon's insulin copycat with a CRL
Oct 9, 2023 11:53am
Novo Nordisk taps Aspen to help produce insulin for Africa
Sep 19, 2023 10:16am
Nine states object to Lilly's $13.5M insulin pricing settlement
Aug 17, 2023 9:40am
FDA again slams Biocon's troubled plant in Malaysia
Aug 17, 2023 8:41am